Concurrently, nuclear factor‐κB (NF‐κB) has emerged as a central transcriptional hub in inflammation‐associated cancers, facilitating proliferation, survival, angiogenesis, immune evasion, and metastasis [4]. This evidence concerns the gene NFKB1 and cancer.